Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3589) 3589
Book Chapter (27) 27
Newsletter (24) 24
Magazine Article (19) 19
Publication (6) 6
Book / eBook (3) 3
Newspaper Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (3050) 3050
humans (2872) 2872
science & technology (2003) 2003
life sciences & biomedicine (1964) 1964
medroxyprogesterone acetate - administration & dosage (1378) 1378
biological and medical sciences (1276) 1276
adult (1263) 1263
middle aged (1240) 1240
medical sciences (1197) 1197
medroxyprogesterone acetate (1116) 1116
obstetrics & gynecology (934) 934
medroxyprogesterone - administration & dosage (712) 712
pharmacology. drug treatments (692) 692
animals (620) 620
medroxyprogesterone - analogs & derivatives (560) 560
medroxyprogesterone acetate - adverse effects (556) 556
aged (552) 552
contraceptive agents, female - administration & dosage (539) 539
medroxyprogesterone (507) 507
gynecology. andrology. obstetrics (484) 484
abridged index medicus (482) 482
medroxyprogesterone acetate - pharmacology (466) 466
pregnancy (459) 459
medroxyprogesterone acetate - therapeutic use (435) 435
adolescent (414) 414
male (394) 394
birth control (379) 379
medroxyprogesterone - pharmacology (370) 370
estrogens, conjugated - administration & dosage (346) 346
estradiol - administration & dosage (344) 344
time factors (344) 344
hormone replacement therapy (342) 342
estrogen replacement therapy (336) 336
menopause (329) 329
contraceptive agents, female - adverse effects (323) 323
delayed-action preparations (322) 322
prospective studies (316) 316
administration, oral (312) 312
medroxyprogesterone - therapeutic use (310) 310
population (303) 303
postmenopause (300) 300
drug administration schedule (292) 292
contraception (290) 290
injections, intramuscular (290) 290
oncology (262) 262
breast neoplasms - drug therapy (261) 261
risk factors (261) 261
drug therapy, combination (258) 258
progesterone (247) 247
treatment outcome (243) 243
obstetrics and gynecology (232) 232
medroxyprogesterone - adverse effects (231) 231
double-blind method (228) 228
reproductive biology (219) 219
hormones. endocrine system (213) 213
women (212) 212
rats (208) 208
health aspects (202) 202
hormonal contraception (202) 202
young adult (202) 202
hormone therapy (201) 201
antineoplastic combined chemotherapy protocols - therapeutic use (199) 199
endocrinology & metabolism (199) 199
estrogen (197) 197
dose-response relationship, drug (192) 192
genital system. reproduction (192) 192
estradiol - pharmacology (179) 179
administration, cutaneous (172) 172
estrogen replacement therapy - adverse effects (172) 172
norethindrone - administration & dosage (172) 172
follow-up studies (168) 168
norethindrone - analogs & derivatives (164) 164
analysis (162) 162
estradiol - blood (160) 160
bone density - drug effects (157) 157
general & internal medicine (155) 155
research (152) 152
medicine, general & internal (151) 151
estradiol - analogs & derivatives (150) 150
antineoplastic agents (148) 148
progesterone congeners - administration & dosage (146) 146
drug combinations (142) 142
breast cancer (138) 138
depot medroxyprogesterone acetate (133) 133
estrogens, conjugated - therapeutic use (131) 131
hormones (130) 130
chemotherapy (127) 127
estradiol (126) 126
injections (125) 125
estrogens - administration & dosage (124) 124
progestins - administration & dosage (124) 124
estrogen replacement therapy - methods (123) 123
estrogens, conjugated - adverse effects (122) 122
contraceptive agents, female - pharmacology (120) 120
endometrium - drug effects (119) 119
contraceptives (118) 118
clinical trials as topic (117) 117
fundamental and applied biological sciences. psychology (117) 117
postmenopausal women (117) 117
breast neoplasms - pathology (116) 116
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3420) 3420
Japanese (149) 149
German (48) 48
Spanish (31) 31
French (24) 24
Italian (24) 24
Chinese (15) 15
Portuguese (13) 13
Polish (11) 11
Dutch (6) 6
Czech (5) 5
Danish (5) 5
Russian (5) 5
Hungarian (3) 3
Swedish (2) 2
Korean (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain
by Crosignani, P.G and Luciano, A and Ray, A and Bergqvist, A
Human reproduction (Oxford), ISSN 0268-1161, 01/2006, Volume 21, Issue 1, pp. 248 - 256
Endometriosis | Bone mineral density | Depot medroxyprogesterone acetate | Subcutaneous injection | Pelvic pain | Leuprolide | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Contraceptive Agents, Female - adverse effects | Bone Density | Lumbar Vertebrae - diagnostic imaging | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Contraceptive Agents, Female - administration & dosage | Treatment Outcome | Administration, Cutaneous | Endometriosis - drug therapy | Uterine Diseases - drug therapy | Radiography | Antineoplastic Agents, Hormonal - adverse effects | Pelvic Pain - drug therapy | Leuprolide - administration & dosage | Medroxyprogesterone Acetate - adverse effects | Quality of Life | Adult | Female | Leuprolide - adverse effects | Hip - diagnostic imaging | Medroxyprogesterone Acetate - administration & dosage | Fertility Agents, Female - administration & dosage | Fertility Agents, Female - adverse effects | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
by Kuang, Yanping, M.D and Chen, Qiuju, Ph.D and Fu, Yonglun, M.D and Wang, Yun, M.D and Hong, Qingqing, M.D and Lyu, Qifeng, Ph.D and Ai, Ai, M.D and Shoham, Zeev, M.D
Fertility and sterility, ISSN 0015-0282, 2015, Volume 104, Issue 1, pp. 62 - 70.e3
Internal Medicine | Obstetrics and Gynecology | Medroxyprogesterone acetate | premature LH surge | controlled ovarian stimulation | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Prospective Studies | Luteinizing Hormone - blood | Administration, Oral | Humans | Contraceptive Agents, Female - administration & dosage | Pregnancy | Luteinizing Hormone - antagonists & inhibitors | Ovulation Induction - methods | Fertilization in Vitro - methods | Female | Medroxyprogesterone Acetate - administration & dosage | Oocyte Retrieval - methods | Infertility, Female - diagnosis | Infertility, Female - therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Depot medroxyprogesterone acetate administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa
by Tasker, Carley and Pizutelli, Vanessa and Lo, Yungtai and Ramratnam, Bharat and Roche, Natalie E and Chang, Theresa L
AIDS (London), ISSN 0269-9370, 04/2020, Volume 34, Issue 5, pp. 729 - 735
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Contraceptive Agents, Female - adverse effects | Contraceptive Agents, Female - therapeutic use | Humans | Medroxyprogesterone Acetate - therapeutic use | Mental Health | Biomarkers - blood | Medroxyprogesterone Acetate - adverse effects | Receptors, CCR5 | Female | Medroxyprogesterone Acetate - administration & dosage | Mucous Membrane - drug effects | Longitudinal Studies | CD4-Positive T-Lymphocytes - drug effects | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg/0.65 mL): A systematic review
by Dragoman, Monica V and Gaffield, Mary E
Contraception (Stoneham), ISSN 0010-7824, 2016, Volume 94, Issue 3, pp. 202 - 215
Obstetrics and Gynecology | DMPA | Safety | Subcutaneous | Depot medroxyprogesterone | Progestogen-only injectables | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Contraceptive Agents, Female - adverse effects | World Health Organization | Obesity - complications | Humans | Contraceptive Agents, Female - administration & dosage | Injections, Intramuscular | Pain - chemically induced | Endometriosis - complications | Delayed-Action Preparations - administration & dosage | Patient Satisfaction | Randomized Controlled Trials as Topic | Bone Density - drug effects | Injections, Subcutaneous | HIV Infections - complications | Medroxyprogesterone Acetate - adverse effects | Female | Weight Gain - drug effects | Medroxyprogesterone Acetate - administration & dosage | Practice Guidelines as Topic | Medroxyprogesterone | Safety and security measures | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
by Halpern, Vera and Brache, Vivian and Taylor, Douglas and Lendvay, Anja and Cochón, Leila and Jensen, Jeffrey T and Dorflinger, Laneta J
Fertility and sterility, ISSN 0015-0282, 01/2021
subcutaneous | pharmacokinetics | Depot medroxyprogesterone acetate | contraception | suppression of ovulation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi
by Burke, Holly M and Packer, Catherine and Buluzi, Mercy and Healy, Elise and Ngwira, Bagrey
Contraception (Stoneham), ISSN 0010-7824, 11/2018, Volume 98, Issue 5, pp. 405 - 410
Community health worker | Self-injection | Family planning | Subcutaneous depot medroxyprogesterone acetate | Malawi | Self-administer | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Medroxyprogesterone | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
: Effects on Bone Mineral Density
by Carr, Bruce and Dmowski, W. Paul and O’Brien, Chris and Jiang, Ping and Burke, Joshua and Jimenez, Roland and Garner, Elizabeth and Chwalisz, Kristof
Reproductive sciences (Thousand Oaks, Calif.), ISSN 1933-7191, 11/2014, Volume 21, Issue 11, pp. 1341 - 1351
Endometriosis | GnRH antagonists | Pelvic pain | Elagolix | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Endometriosis - diagnosis | United States | Humans | Pelvic Pain - diagnosis | Endometriosis - complications | Hydrocarbons, Fluorinated - administration & dosage | Pelvic Pain - drug therapy | Time Factors | Injections, Subcutaneous | Adult | Female | Medroxyprogesterone - administration & dosage | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Endometriosis - drug therapy | Absorptiometry, Photon | Hormone Antagonists - administration & dosage | Bone Density - drug effects | Pelvic Pain - etiology | Texas | Endometriosis - metabolism | Gonadotropin-Releasing Hormone - metabolism | Pyrimidines - adverse effects | Medroxyprogesterone - adverse effects | Pain Measurement | Delayed-Action Preparations | Hormone Antagonists - adverse effects | Hydrocarbons, Fluorinated - adverse effects | Index Medicus | endometriosis | pelvic pain | elagolix | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial
by Raymond, Elizabeth G and Weaver, Mark A and Louie, Karmen S and Tan, Yi-Ling and Bousiéguez, Manuel and Aranguré-Peraza, Ana Gabriela and Lugo-Hernández, Elba M and Sanhueza, Patricio and Goldberg, Alisa B and Culwell, Kelly R and Kaplan, Clair and Memmel, Lisa and Sonalkar, Sarita and Jamshidi, Roxanne and Winikoff, Beverly
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 10/2016, Volume 128, Issue 4, pp. 739 - 745
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Abortifacient Agents, Steroidal - administration & dosage | Humans | Contraceptive Agents, Female - administration & dosage | Treatment Outcome | Injections, Intramuscular | Delayed-Action Preparations - administration & dosage | Patient Satisfaction | Pregnancy | Young Adult | Abortion, Induced - adverse effects | Time Factors | Adolescent | Adult | Female | Medroxyprogesterone Acetate - administration & dosage | Pregnancy Rate | Mifepristone - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review
by Dianat, Shokoufeh and Fox, Edith and Ahrens, Katherine A and Upadhyay, Ushma D and Zlidar, Vera M and Gallo, Maria F and Stidd, Reva L and Moskosky, Susan and Dehlendorf, Christine
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 02/2019, Volume 133, Issue 2, pp. 332 - 341
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Medroxyprogesterone | Complications and side effects | Contraception | Dosage and administration | Patient outcomes | Methods | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Depot Medroxyprogesterone Acetate and Bone Mineral Density in Adolescents—The Black Box Warning: A Position Paper of the Society for Adolescent Medicine
by Cromer, Barbara A and Scholes, Delia and Berenson, Abbey and Cundy, Tim and Clark, M. Kathleen and Kaunitz, Andrew M and Society for Adolescent Medicine
Journal of adolescent health, ISSN 1054-139X, 2006, Volume 39, Issue 2, pp. 296 - 301
Pediatrics | Social Sciences | Life Sciences & Biomedicine | Psychology | Public, Environmental & Occupational Health | Psychology, Developmental | Science & Technology | Fundamental and applied biological sciences. Psychology | Gynecology and obstetrics | Biological and medical sciences | Psychology. Psychoanalysis. Psychiatry | Psychology and medicine | Psychology. Psychophysiology | Contraceptive Agents, Female - adverse effects | Calcium, Dietary | United States | Humans | Contraceptive Agents, Female - administration & dosage | Adolescent Medicine | Contraindications | Bone Density - drug effects | Drug Labeling | Fractures, Bone - etiology | Societies, Medical | Adolescent | Counseling | Medroxyprogesterone Acetate - adverse effects | Female | Bone Resorption - chemically induced | Medroxyprogesterone Acetate - administration & dosage | Delayed-Action Preparations | United States Food and Drug Administration | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device
by van Hylckama Vlieg, Astrid and Helmerhorst, Frans M and Rosendaal, Frits R
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 11/2010, Volume 30, Issue 11, pp. 2297 - 2300
nonoral contraceptives | risk factors | hormone-releasing IUD | injectable DMPA | venous thrombosis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Atherosclerosis (general aspects, experimental research) | Biological and medical sciences | Medical sciences | Coronary heart disease | Blood and lymphatic vessels | Contraceptive Agents, Female - adverse effects | Venous Thrombosis - chemically induced | Humans | Middle Aged | Risk Factors | Contraceptive Agents, Female - administration & dosage | Intrauterine Devices - adverse effects | Case-Control Studies | Venous Thrombosis - etiology | Young Adult | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Adolescent | Medroxyprogesterone Acetate - adverse effects | Adult | Female | Medroxyprogesterone Acetate - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)
by Katz, Micah and Newmark, Rebecca L and Aronstam, Alison and O'Grady, Niamh and Strome, Sara and Rafie, Sally and Karlin, Jennifer
Contraception (Stoneham), ISSN 0010-7824, 12/2020, Volume 102, Issue 6, pp. 392 - 395
Contraceptive access | COVID-19 response | Depomedroxyprogesterone acetate | Reproductive autonomy | Injectable contraception | Primary Health Care - methods | United States | Humans | Middle Aged | Hormonal Contraception - methods | California | Patient Acceptance of Health Care - statistics & numerical data | COVID-19 - prevention & control | Young Adult | Contraceptive Agents, Hormonal - administration & dosage | Self Administration | Safety-net Providers | Injections, Subcutaneous | Telemedicine - methods | Adolescent | Adult | Female | Medroxyprogesterone Acetate - administration & dosage | Medicaid | Medroxyprogesterone | Birth control | Pregnant women | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Tenofovir Disoproxil Fumarate Intravaginal Ring Protects High-Dose Depot Medroxyprogesterone Acetate–Treated Macaques From Multiple SHIV Exposures
by Smith, James M and Srinivasan, Priya and Teller, Ryan S and Lo, Yungtai and Dinh, Chuong T and Kiser, Patrick F and Herold, Betsy C
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 01/2015, Volume 68, Issue 1, pp. 1 - 5
macaque | PrEP | Depo-Provera | Intravaginal ring | TDF | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | HIV Infections - prevention & control | Macaca nemestrina | Adenine - analogs & derivatives | Vagina | Phosphorous Acids - administration & dosage | Adenine - administration & dosage | Anti-HIV Agents - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Animals | Adenine - therapeutic use | Phosphorous Acids - therapeutic use | Placebos | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Simian Acquired Immunodeficiency Syndrome - transmission | Medroxyprogesterone Acetate - administration & dosage | Delayed-Action Preparations | Disease prevention | Antiretroviral drugs | Monkeys & apes | Human immunodeficiency virus--HIV | Index Medicus | AIDS/HIV | Macaque | intravaginal ring
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights